Lawsuit Filed Against ReNu with MoistureLoc Maker

 

Hissey Kientz, LLP Files Lawsuit Against ReNu with MoistureLoc Maker

The law office of Hissey Kientz announced this week that it has filed a lawsuit against Bausch & Lomb on behalf of a 16-year-old girl who suffered corneal scarring due to a severe eye infection (Case No. 2:07-CV-00954).

Austin, TX (PRWEB) May 26, 2007 -- The law office of Hissey Kientz announced this week that it has filed a lawsuit against Bausch & Lomb on behalf of a 16-year-old girl who suffered corneal scarring due to a severe eye infection (Case No. 2:07-CV-00954). The lawsuit alleges that the victim's use of Bausch & Lomb's ReNu with MoistureLoc contact lens solution caused her to develop a severe eye infection (keratitis), leading to permanent corneal scarring and eye damage.

According to the lawsuit, the victim began to experience severe eye pain in February 2005 and went to her doctor. After an examination, she was diagnosed with a corneal infiltrate, as well as fungal and bacterial keratitis infections.

Although doctors cleared the victim's eye of infection after two weeks of treatment, she suffered permanent scarring on the surface of her eye and may require a corneal transplant in the future to repair the damage.

Bausch & Lomb released ReNu with MoistureLoc in November 2004 in the United States, Europe and Asia. In November 2005, health officials in Singapore and Hong Kong notified Bausch & Lomb of a growing number of Fusarium keratitis infections among MoistureLoc users.

Bausch & Lomb suspended sales of MoistureLoc in Singapore and Hong Kong in February 2006, but failed to alert users and health officials in the United States or Europe of the potential link between ReNu with MoistureLoc and harmful eye infections.

In March 2006, doctors in the U.S. began reporting cases of Fusarium keratitis to the CDC. On April 10, 2006, the CDC released data which confirmed that almost 90% of patients with Fusarium keratitis were users of ReNu with MoistureLoc. Bausch & Lomb suspended U.S. sales in April 2006, but did not notify users or issue a recall. Instead, Bausch & Lomb increased production of alternative lens solutions which did not contain the ingredients in its MoistureLoc solution.

Bausch & Lomb finally issued a worldwide ReNu recall in May 2006 after an investigation by the CDC linked MoistureLoc to more than 100 cases of Fusarium keratitis.

Fusarium keratitis is a type of fungal infection which inflames the cornea and may cause corneal ulcers, blurry vision, pain, excessive discharge from the eye, increased light sensitivity, degenerative scarring of the cornea, diminished vision and blindness.

The disease causes permanent corneal scarring and is degenerative. Due to the prior rarity of Fusarium keratitis, physicians may erroneously diagnose the condition as pink eye or conjunctivitis. Once diagnosed, 30% to 50% of all Fusarium keratitis infections eventually require a corneal transplant.

Claims have been filed against Bausch & Lomb for the company's failure to disclose the problems associated with ReNu with MoistureLoc. Former patients have alleged that Bausch & Lomb knew about the link between Fusarium keratitis and MoistureLoc as early as November 2005, but failed to warn them in time to prevent severe damage to their eyesight.

Hissey Kientz, LLP and its team of experienced mass tort lawyers have been retained in many cases nationwide involving ReNu with MoistureLoc.

About Hissey Kientz, LLP
Hissey Kientz, LLP is currently handling cases involving people affected by Avandia, Zyprexa, Fosamax, the Ortho Evra patch, Ketek, Vioxx, heart devices, hormone replacement therapy and other defective drugs. To learn more about the firm and other potentially dangerous drug cases, visit Hissey Kientz, LLP (www.hkllp.com) or call (866) 275-4454.

#-##

Press Contact: Todd Greenbaum
Company Name: Hissey Kientz, LLP
Phone: 866 275-4454
Website: http://www.renurecallinfo.com